tiprankstipranks
Rapid Dose Therapeutics Corp (TSE:DOSE)
CNQX:DOSE
Canadian Market

Rapid Dose Therapeutics Corp (DOSE) Financial Statements

5 Followers

Rapid Dose Therapeutics Corp Financial Overview

Rapid Dose Therapeutics Corp's market cap is currently ―. The company's EPS TTM is C$-0.039; its P/E ratio is -4.82; Rapid Dose Therapeutics Corp is scheduled to report earnings on July 30, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 23Aug 23May 23Feb 23Nov 22
Income Statement-
Total RevenueC$ 233.81KC$ 353.17KC$ 240.79KC$ 217.35KC$ 305.63K
Gross ProfitC$ 129.40KC$ 243.94KC$ 117.61KC$ 28.65KC$ 227.49K
EBITC$ -878.49KC$ -556.40KC$ -465.17KC$ -1.16MC$ -531.65K
EBITDAC$ -725.65KC$ -416.21KC$ -318.66KC$ -878.00KC$ -419.65K
Net Income Common StockholdersC$ -981.08KC$ -730.68KC$ -544.80KC$ -1.30MC$ -583.50K
Balance Sheet-
Cash Cash Equivalents And Short Term InvestmentsC$ 166.18KC$ 203.43KC$ 32.80KC$ 27.59KC$ 26.37K
Total AssetsC$ 1.99MC$ 2.10MC$ 2.07MC$ 2.25MC$ 2.74M
Total DebtC$ 2.70MC$ 2.46MC$ 1.76MC$ 1.61MC$ 1.40M
Net DebtC$ 2.53MC$ 2.26MC$ 1.73MC$ 1.58MC$ 1.37M
Total LiabilitiesC$ 6.53MC$ 5.94MC$ 5.31MC$ 4.92MC$ 4.16M
Stockholders EquityC$ -4.54MC$ -3.84MC$ -3.24MC$ -2.67MC$ -1.43M
Cash Flow-
Free Cash Flow-C$ -183.23KC$ -132.76KC$ -89.74KC$ -774.18K
Operating Cash FlowC$ -672.67KC$ -183.23KC$ -132.76KC$ -89.74KC$ -774.18K
Investing Cash Flow-----
Financing Cash FlowC$ 635.42KC$ 353.84KC$ 137.98KC$ 90.94KC$ 765.59K
Currency in CAD

Rapid Dose Therapeutics Corp Earnings and Revenue History

Rapid Dose Therapeutics Corp Debt to Assets

Rapid Dose Therapeutics Corp Cash Flow

Rapid Dose Therapeutics Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis